Jiangsu Nutai Biologics Co., Ltd
2 clinical trials · Sponsor
◉ Watch Jiangsu Nutai Biologics Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia (NCT07231120) | Jiangsu Nutai Biologics Co., Ltd | 2025-11-17 |
| A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors (NCT06736275) | Jiangsu Nutai Biologics Co., Ltd | 2024-09-02 |
Track Jiangsu Nutai Biologics Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.